Bulls regain winning touch…Nifty above 5100India Infoline.comComing back to India, among the BSE sectoral indices, the realty index was the top gainer, adding 6%, followed by the Auto index that was up 3% and the BSE ...and more »

Attitude of investigators & quality parameters prevent early human ...pharmabiz.com, IndiaTherefore Indian CROs lacked the skills of early clinical development especially in translational research and proof of concept studies. The main hindrance to clinical research in India is the lack of a structured roadmap. ...'Reorientation' can help Indian CROs to compete with their Western ... Equity BullsAs world looks to India, biotech industry readies for take-off mydigitalfc.comall 3 news articles

'Reorientation' can help Indian CROs to compete with their Western ...Equity Bulls, IndiaPeople with lot of patience are needed for clinical research work. As clinical research is a global industry though it is working out of India, there is a need to balance so many things like work vs home, today vs tomorrow etc. ...

Mangalorean.comBangalore Bio 2009: Indian Clinical Research Industry has Hit a ...Equity Bulls, IndiaDr. Anand Bidarkar, Vice-President, SIRO Clinpharm Pvt. Ltd. said the main hindrance to clinical research in India is the lack of a structured roadmap. "We have MNC CROs in India but, they limit their role to a need basis. ...State to finalize new policies for biotech and IT Times of IndiaBiotech regulator on cards, says Prithviraj Chavan domain-BK'taka to unveil revised biotech policy Mangalorean.comBusiness Wire India (press release) - Equity Bullsall 64 news articles

SIU medical student wins Fulbright ScholarshipThe State Journal-Register, ILVohra will travel to India in August for nine months of clinical research into hospital based infections on a Fulbright scholarship. Jason Johnson/The State Journal-Register By DEAN OLSEN Sameer Vohra was born in Chicago, grew up rooting for the Bulls ...

Suven Life completes Phase I Clinical Trials Multiple Ascending ...Equity Bulls, IndiaHyderabad, India April 9, 2009 – Suven Life Sciences Ltd, a Drug Discovery and development company announced today that it has completed its Phase 1 multiple ascending dose study of SUVN-502 in healthy volunteers. SUVN-502 is a potent, safe, ...

Business StandardEli Lilly, Zydus Cadila enter drug development dealBusiness Standard, IndiaZydus will work to discover and develop potential molecules against a novel drug target, primarily in the area of cardiovascular research. This will include lead identification and optimization, pre-clinical trials and clinical trials up to second ...Cadila Health Signs Drug Devt Pact With Eli Lilly Wall Street JournalIndia Cadila and Eli Lilly in drug development deal ReutersZydus Cadila inks agreement with Eli Lilly for new drug discovery ... Equity BullsTrading Markets (press release)all 47 news articles

RTT NewsCadila Health Signs Drug Devt Pact With Eli LillyCNNMoney.comSuch a deal means that its multinational partner has faith and confidence in Cadila's drug discovery research operations," said Ranjit Kapadia, head of research for private client group at brokerage Prabhudas Lilladher. Last year, the mid-sized ...India Cadila and Eli Lilly in drug development deal ReutersZydus Cadila inks agreement with Eli Lilly for new drug discovery ... Equity Bullsall 21 news articles

Frontier Mediville to be established at ElavurEquity Bulls, IndiaIn the world of medicine as in other industries, technology is changing at a rapid pace; given India's large pool of trained manpower in medicine, healthcare, life sciences and clinical data, it has been recognized that a single venue, which will bring ...Frontier Mediville gets India’s first hospital SEZ Economic TimesNational medical science park Express BuzzFrontier Mediville gets SEZ status, to set up medical science park ... Financial ExpressTimes of Indiaall 5 news articles

Apollo Hospitals, Quintiles to set up Phase I Clinical Trial ...Equity Bulls, India - 1 hour ago... in association with Apollo Hospitals, India, the largest health care service provider in India, will be setting up a Phase I clinical trial research ...